RO-5429083

• Description:

  RO-5429083 is a humanized monoclonal antibody inhibitor targeting CD44. RO-5429083 can be used for acute myeloid leukemia (AML) and solid tumors research[1].

• Product Name Alternative:

  RG-7356

• UNSPSC:

  12352203

• Target:

  Transmembrane Glycoprotein

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Purity:

  96.78

• References & Citations:

  [1]Yang XG, et al. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity. Front Oncol. 2019 Sep 10;9:887.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  -80°C

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported